International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 167-169 doi: 10.5281/zenodo.16459279
Case Report
Golden ‘Reverse S Sign’ – A Reliable Sign of Lung Cancer: A Case Report
 ,
 ,
 ,
Published
July 26, 2025
Abstract

Introduction: The "Golden S Sign" is a classic radiologic indicator of bronchogenic carcinoma, especially when involving the right upper lobe bronchus. Early recognition of such signs can prompt further investigation and diagnosis of lung malignancy.

Case Presentation: A 65-year-old male chronic smoker presented with hemoptysis, breathlessness, chest pain, fever, and weight loss. Chest X-ray revealed right upper lobe collapse and hilar prominence. CT scan and bronchoscopy confirmed the presence of a necrotic mass obstructing the right upper lobe bronchus. Histopathological analysis revealed poorly differentiated non-small cell carcinoma.

Conclusion: Despite initial CT-guided biopsy being inconclusive, radiological suspicion guided further diagnostic steps, confirming malignancy. This case highlights the importance of the "Golden S Sign" as a reliable early radiologic clue for lung cancer.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
2014 Views
116 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved